Revolution Medicines, Inc. (RVMDW)Redwood City, United States | NasdaqGS
5.43 USD
-0.08
(-1.452%) ⇩
(April 17, 2026, 3:57 p.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:07 p.m. EDT
CRITICAL LORAX DOWNSIDE: 17.64 million shares (Dir sale) combined with massive negative free cash flow (-$523M FCFF, -$897M OCF) and zero recent price movement after hitting $5.77 high. Sponsor holding (W) trapped at near-block bottom. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 26.185 |
| Beta | 1.01 |
| Website | https://www.revmed.com |
| Attribute | Value |
|---|---|
| Address1 | 700 Saginaw Drive |
| Ask | 0.3899 |
| Ask Size | 2 |
| Beta | 1.012 |
| Bid | 0.3517 |
| Bid Size | 20 |
| Book Value | 8.281 |
| City | Redwood City |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.43 |
| Current Ratio | 7.145 |
| Custom Price Alert Confidence | HIGH |
| Day High | 5.77 |
| Day Low | 5.21 |
| Debt To Equity | 26.185 |
| Display Name | Revolution Medicines |
| Ebitda | -1,174,619,008 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 5.77 |
| Fifty Two Week High Change | -0.34000015 |
| Fifty Two Week High Change Percent | -0.058925502 |
| Fifty Two Week Low | 5.21 |
| Fifty Two Week Low Change | 0.21999979 |
| Fifty Two Week Low Change Percent | 0.04222645 |
| Fifty Two Week Range | 5.21 - 5.77 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 178,734,568 |
| Free Cashflow | -523,279,008 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 883 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -987,331,968 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,023-11-17 |
| Language | en-US |
| Long Business Summary | Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California. |
| Long Name | Revolution Medicines, Inc. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_283775412 |
| Net Income To Common | -1,131,300,992 |
| Open | 0.386 |
| Operating Cashflow | -897,740,992 |
| Operating Margins | 0.0 |
| Phone | 650 481 6801 |
| Previous Close | 5.51 |
| Price Hint | 2 |
| Price To Book | 0.65571785 |
| Profit Margins | 0.0 |
| Quick Ratio | 6.975 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0800004 |
| Regular Market Change Percent | -1.4519128 |
| Regular Market Day High | 5.77 |
| Regular Market Day Low | 5.21 |
| Regular Market Day Range | 5.21 - 5.77 |
| Regular Market Open | 0.386 |
| Regular Market Previous Close | 5.51 |
| Regular Market Price | 5.43 |
| Regular Market Time | 1,776,455,839 |
| Regular Market Volume | 140,460 |
| Return On Assets | -0.30084 |
| Return On Equity | -0.58068 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | Revolution Medicines, Inc. Warr |
| Source Interval | 15 |
| State | CA |
| Symbol | RVMDW |
| Total Cash | 2,025,678,976 |
| Total Cash Per Share | 10.222 |
| Total Debt | 427,148,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 140,460 |
| Website | https://www.revmed.com |
| Zip | 94,063 |